Carbidopa Tablet
Product Images NDC 68682-200

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carbidopa (NDC 68682-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (44507259 7cb9 4044 8f6b E4c253ae2b31 01)

Chemical structure of Carbidopa shown with a phenyl ring bearing hydroxyl groups, attached to a hydrazine carboxylic acid side chain with a methyl group, and a water molecule as hydrate indicated.*

FDA Label Image

Label

Carbidopa Tablets label showing 25 mg strength in tablet form, with a package size of 100 tablets. The label includes the NDC 68682-200-25 and indicates the product is for prescription use only. Distributed by Oceanside Pharmaceuticals and manufactured by Bausch Health Companies Inc., Canada. The label features storage instructions and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.